Barbiturate Drug Market

Future Market Insights

Key Insight

The barbiturate drug market is projected to grow from USD 508.6 million in 2025 to USD 696.9 million by 2035, at a CAGR of 3.2%. Long-Acting Barbiturate will dominate with a 41.7% market share, while insomnia will lead the applications segment with a 38.2% share.

October 08, 2025

Anurag Sharma

309 Pages

Cite this Report

Barbiturate Drug Market

https://www.futuremarketinsights.com/reports/barbiturate-drug-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Abbott
Centurion Healthcare Private Limited
Ethypharm S.A
GSK plc
Intas Pharmaceuticals Ltd
Novartis
Par Pharmaceutical Inc
Samarth Life Science Pvt. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Barbiturate Drug Market

Key Players

Similar Industry Reports